Prevention of Obesity and Insulin Resistance by Estrogens Requires ERα Activation Function-2 (ERαAF-2), Whereas ERαAF-1 Is Dispensable

The beneficial metabolic actions of estrogen-based therapies are mainly mediated by estrogen receptor α (ERα), a nuclear receptor that regulates gene transcription through two activation functions (AFs): AF-1 and AF-2. Using mouse models deleted electively for ERαAF-1 (ERαAF-1°) or ERαAF-2 (ERαAF-2°...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Handgraaf, Sandra, Riant, Elodie, Fabre, Aurélie, Waget, Aurélie, Burcelin, Rémy, Lière, Philippe, Krust, Andrée, Chambon, Pierre, Arnal, Jean-François, Gourdy, Pierre
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837069/
https://ncbi.nlm.nih.gov/pubmed/23903353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db13-0282
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires